⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery
globenewswire.com
ILMN
DHR
BDX
BIO
BRKR
QGEN
XRAY
EXAS
TMO
ABT
AMGN
AGNC
AMZN
GOOG
QNRX
NVDA
IBM
MRNA
PFE
JNJ
BMY
GILD
AMAT
ASML
LRCX
KLAC
MU
AMD
INTC
SNOW
CRSP
EDIT
BEAM
REGN
VRTX
BIIB
LLY
ACN
MSFT
XOM
CVX
Les investissements dans l’IA explosent, mais les entreprises peinent à en démontrer la valeur, selon une étude mondiale de HTEC
businesswire.com
NVDA
MSFT
GOOG
AMZN
META
IBM
INTC
AMD
QCOM
MU
AMAT
ASML
TXN
ADI
MRVL
LRCX
KLAC
CRDO
CSCO
AVGO
MCHP
NXPI
ON
TER
GILD
AMGN
BMY
PFE
MRK
JNJ
ACN
T
VZ
TMUS
GM
F
STLA
Antiviral Drugs Market to Reach USD 125.26 Billion by 2035 - Credence Research
prnewswire.com
GILD
VIV
MRK
PFE
mRNA Drug Discovery and Manufacturing Platforms Market - Size, Share, Trends, and Forecast 2026-2031 | 11.5% CAGR to USD 0.81 Billion as Oncology and AI-Enabled R&D Scale
globenewswire.com
MRNA
BNTX
CVAC
PFE
GSK
Global Biomarker-Driven Drug Development Market - Strategic Insights and Forecasts, 2026-2031 | Precision Medicine and Multi-Omics Drive 10.2% CAGR to USD 35.9 Billion
globenewswire.com
PFE
MRK
AMGN
LLY
GILD
Roxus® ED Nasal Spray Now Available in the U.S.: Peak Blood Levels in About 10 Minutes, Not an Hour
prnewswire.com
PFE
Peripheral T-Cell Lymphoma (PTCL) Market Insights, Epidemiology, and Forecast, 2026-2036 | 7MM Market to Double to $1.6 Billion as Targeted Therapies Drive 7% CAGR
globenewswire.com
PFE
TSEM
CRSP
BCRX
MRK
BMY
Cocaine Use Disorder Market Outlook to Strengthen During the Forecast Period (2026-2036) with Emerging Therapies and Rising Healthcare Needs | DelveInsight
prnewswire.com
OMER
ALKS
TEVA
PFE
LLY
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
businesswire.com
PFE
ALK-Positive Non-Small Cell Lung Cancer Market, Epidemiology, and 7MM Forecast to 2036 | Market to Reach USD 3.37 Billion as Next-Generation ALK Inhibitors Drive Growth
globenewswire.com
PFE
TAK